Prequalification Update - 15 November 2010

WHO Prequalification Programme publishes a new WHO Public Assessment Report (WHOPAR)

     The WHOPAR covers the following products:

• HA414 - Lamivudine/Tenofovir disoproxil fumarate - 300mg/300mg - Tablets - Matrix Laboratories Ltd - INDIA
  
  

Related Link:  Overview of WHOPARs of Prequalified Medicinal Products